Literature DB >> 15007517

[Markers in patients with squamous cell carcinoma of the oral cavity. Expression and long-term follow-up of VEGF, FLT-1 and Tie2 in serum].

R Schimming1, N-C Gellrich, G Eyrich.   

Abstract

OBJECTIVE: The quantification of serum or plasma levels of angiogenic factors in patients with malignancies aims at the description of these factors or their receptors and allows a tissue independent study of biological tumor behavior.
METHODS: In 51 patients with untreated squamous cell carcinoma of the oral cavity (SCCOC) and 10 healthy controls, plasma levels of VEGF and serum levels of the VEGF-receptor FLT-1 and the Ang1-receptor Tie2 were measured. Using an ELISA technique, the concentration of these factors was measured preoperatively and postoperatively over a period of 5 weeks.
RESULTS: No statistically significant correlation could be found between the serum and plasma levels and the clinical or pathological parameters. There was no difference between the patients with SCCOC and healthy controls.
CONCLUSIONS: In patients with SCCOC, plasma levels of VEGF and serum levels of FLT-1 and Tie-2 do not provide any further information on the biological tumor behavior like proliferation or expression of metastases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007517     DOI: 10.1007/s00106-003-0915-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  23 in total

Review 1.  [Mechanisms of invasiveness of cancers of the head and neck region].

Authors:  C Simon; M Simon; H P Zenner
Journal:  HNO       Date:  2001-11       Impact factor: 1.284

2.  High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.

Authors:  P Salven; T Ruotsalainen; K Mattson; H Joensuu
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

3.  Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.

Authors:  C N Qian; C Q Zhang; X Guo; M H Hong; S M Cao; W Y Mai; H Q Min; Y X Zeng
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

4.  [Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck].

Authors:  A Dietz; V Rudat; B Vanselow; C Conradt; T Möhler
Journal:  HNO       Date:  1999-08       Impact factor: 1.284

5.  Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking.

Authors:  T Wasada; R Kawahara; K Katsumori; M Naruse; Y Omori
Journal:  Metabolism       Date:  1998-01       Impact factor: 8.694

6.  Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

Authors:  P Salven; A Orpana; H Joensuu
Journal:  Clin Cancer Res       Date:  1999-03       Impact factor: 12.531

7.  Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.

Authors:  K Werther; I J Christensen; N Brünner; H J Nielsen
Journal:  Eur J Surg Oncol       Date:  2000-11       Impact factor: 4.424

8.  Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family.

Authors:  P C Maisonpierre; M Goldfarb; G D Yancopoulos; G Gao
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

9.  Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.

Authors:  A Kraft; K Weindel; A Ochs; C Marth; J Zmija; P Schumacher; C Unger; D Marmé; G Gastl
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

10.  Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients.

Authors:  M Kitamura; M Toi; K Arai; Y Iwasaki; H Suzuki; K Matsuo
Journal:  Oncol Rep       Date:  1998 Nov-Dec       Impact factor: 3.906

View more
  1 in total

Review 1.  Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease.

Authors:  T Makinde; D K Agrawal
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.